EICOSAPENTAENOIC ACID INHIBITS CELL-GROWTH AND TRIACYLGLYCEROL SECRETION IN MCA-RH7777 RAT HEPATOMA CULTURES

被引:18
作者
FOX, JC
HAY, RV
机构
[1] UNIV MICHIGAN HOSP, MED CTR, DIV NUCL MED, BIG412, ANN ARBOR, MI 48109 USA
[2] UNIV CHICAGO, DEPT PATHOL, CHICAGO, IL 60637 USA
[3] UNIV CHICAGO, SPECIALIZED CTR RES ATHEROSCLEROSIS, CHICAGO, IL 60637 USA
关键词
D O I
10.1042/bj2860305
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The plasma triacylglycerol-decreasing effect of fish-oil fatty acids was studied in vitro by using the rapidly growing cultured rat hepatoma cell line McA-RH7777. Cells were exposed to albumin-complexed eicosapentaenoic acid (C20:5n-3; EPA), to oleic acid (C18:1n-9; OA), or to albumin alone. Cell growth was similar in albumin- and OA-supplemented cultures, but EPA treatment inhibited growth. As estimated by [C-14]glycerol incorporation, OA stimulated both net triacylglycerol synthesis and secretion over control levels in a dose-dependent manner. EPA stimulated triacylglycerol synthesis in similar fashion to OA, but paradoxically decreased net triacylglycerol secretion and led to exaggerated intracellular accumulation of radiolabelled triacylglycerol. The EPA and OA effects were additive at low concentrations of total fatty acid, but at higher fatty acid concentrations OA appeared to negate some effects of EPA. Chemical analysis of albumin- and OA-treated cultures revealed OA-dominant profiles for both cellular and medium triacylglycerol-associated fatty acids. In contrast, EPA was the principal fatty acid in cellular triacylglycerol of EPA-supplemented cultures, whereas medium triacylglycerol from these cultures contained very little EPA. We conclude that McA-RH7777 hepatoma cells readily synthesize EPA-containing triacylglycerol molecules, but they have variable capacity for secreting them. We consider potential mechanisms to account for the effects of EPA in this system.
引用
收藏
页码:305 / 312
页数:8
相关论文
共 76 条
  • [1] APPLEGATE KR, 1991, J LIPID RES, V32, P1645
  • [2] APPLEGATE KR, 1991, J LIPID RES, V32, P1635
  • [3] OMEGA-3 FATTY-ACIDS IN DIABETES-MELLITUS - GIFT FROM THE SEA
    AXELROD, L
    [J]. DIABETES, 1989, 38 (05) : 539 - 543
  • [4] Becker J.E, 1976, ONCO DEVELOPMENTAL G, P259
  • [5] THE DIFFERENTIAL EFFECT OF EICOSAPENTAENOIC ACID AND OLEIC-ACID ON LIPID-SYNTHESIS AND VLDL SECRETION IN RABBIT HEPATOCYTES
    BENNER, KG
    SASAKI, A
    GOWEN, DR
    WEAVER, A
    CONNOR, WE
    [J]. LIPIDS, 1990, 25 (09) : 534 - 540
  • [6] INTESTINAL AND HEPATIC APOLIPOPROTEIN-B GENE-EXPRESSION IN ABETALIPOPROTEINEMIA
    BLACK, DD
    HAY, RV
    ROHWERNUTTER, PL
    ELLINAS, H
    STEPHENS, JK
    SHERMAN, H
    TENG, BB
    WHITINGTON, PF
    DAVIDSON, NO
    [J]. GASTROENTEROLOGY, 1991, 101 (02) : 520 - 528
  • [7] SPECIFIC SUSCEPTIBILITY OF DOCOSAHEXAENOIC ACID AND EICOSAPENTAENOIC ACID TO PEROXIDATION IN AQUEOUS-SOLUTION
    BRUNA, E
    PETIT, E
    BELJEANLEYMARIE, M
    HUYNH, S
    NOUVELOT, A
    [J]. LIPIDS, 1989, 24 (11) : 970 - 975
  • [8] CHEN RF, 1967, J BIOL CHEM, V242, P173
  • [9] DIETARY FISH OIL DECREASES VLDL PRODUCTION-RATES
    DAGGY, B
    AROST, C
    BENSADOUN, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 920 (03) : 293 - 300
  • [10] FISH OIL SUPPLEMENTATION REDUCES BETA-VERY LOW-DENSITY-LIPOPROTEIN IN TYPE-III DYSBETALIPOPROTEINEMIA
    DALLONGEVILLE, J
    BOULET, L
    DAVIGNON, J
    LUSSIERCACAN, S
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (04): : 864 - 871